182 related articles for article (PubMed ID: 33740951)
1. Preoperative C-reactive protein to albumin ratio and oral health in oral squamous cell carcinoma patients.
Keinänen A; Uittamo J; Marinescu-Gava M; Kainulainen S; Snäll J
BMC Oral Health; 2021 Mar; 21(1):132. PubMed ID: 33740951
[TBL] [Abstract][Full Text] [Related]
2. Preoperative high c-reactive protein/albumin ratio is a poor prognostic factor of oral squamous cell carcinoma.
Wang Q; Song X; Zhao Y; He Q; Shi M; Xu P; Ni S; Chen Y; Lin J; Zhang L
Future Oncol; 2019 Jul; 15(19):2277-2286. PubMed ID: 31237166
[No Abstract] [Full Text] [Related]
3. Influence of the Preoperative C-Reactive Protein-to-Albumin Ratio on Survival and Recurrence in Patients With Esophageal Cancer.
Tamagawa H; Aoyama T; Tamagawa A; Komori K; Maezawa Y; Kano K; Murakawa M; Atsumi Y; Hara K; Kazama K; Numata M; Oshima T; Yukawa N; Masuda M; Rino Y
Anticancer Res; 2020 Apr; 40(4):2365-2371. PubMed ID: 32234939
[TBL] [Abstract][Full Text] [Related]
4. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio.
Wei XL; Wang FH; Zhang DS; Qiu MZ; Ren C; Jin Y; Zhou YX; Wang DS; He MM; Bai L; Wang F; Luo HY; Li YH; Xu RH
BMC Cancer; 2015 May; 15():350. PubMed ID: 25934640
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein to albumin ratio is a prognostic factor for patients with cStage II/III esophageal squamous cell cancer.
Otowa Y; Nakamura T; Yamamoto M; Kanaji S; Matsuda Y; Matsuda T; Oshikiri T; Sumi Y; Suzuki S; Kakeji Y
Dis Esophagus; 2017 Dec; 30(12):1-5. PubMed ID: 28881893
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein/albumin ratio as prognostic score in oral squamous cell carcinoma.
Park HC; Kim MY; Kim CH
J Korean Assoc Oral Maxillofac Surg; 2016 Oct; 42(5):243-250. PubMed ID: 27847731
[TBL] [Abstract][Full Text] [Related]
7. Can C-reactive protein-based biomarkers be used as predictive of 30-day mortality in elderly hip fractures?A retrospective study.
Balta O; Altınayak H; Gürler Balta M; Astan S; Uçar C; Kurnaz R; Zengin EC; Eren MB
Ulus Travma Acil Cerrahi Derg; 2022 Jun; 28(6):849-856. PubMed ID: 35652864
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer.
Liu Y; Chen S; Zheng C; Ding M; Zhang L; Wang L; Xie M; Zhou J
BMC Cancer; 2017 Apr; 17(1):285. PubMed ID: 28431566
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin in Patients with Colorectal Cancer.
Shibutani M; Maeda K; Nagahara H; Iseki Y; Ikeya T; Hirakawa K
Anticancer Res; 2016 Mar; 36(3):995-1001. PubMed ID: 26976989
[TBL] [Abstract][Full Text] [Related]
10. [Preoperative C-reactive protein/albumin ratio predicts the prognosis of patients with resectable pancreatic cancer].
Luo BY; Yang Y; Duan YF; Cai HH; An Y; Sun DL
Zhonghua Wai Ke Za Zhi; 2018 Sep; 56(9):712-717. PubMed ID: 30157579
[No Abstract] [Full Text] [Related]
11. Postoperative ratio of C-reactive protein to albumin is an independent prognostic factor for gastric cancer.
Li C; Yang X; Li H; Fu Y; Wang W; Jin X; Bian L; Peng L
Eur J Med Res; 2023 Sep; 28(1):360. PubMed ID: 37735699
[TBL] [Abstract][Full Text] [Related]
12. A Novel Inflammation-Based Prognostic Score, the C-Reactive Protein/Albumin Ratio Predicts the Prognosis of Patients with Operable Esophageal Squamous Cell Carcinoma.
Xu XL; Yu HQ; Hu W; Song Q; Mao WM
PLoS One; 2015; 10(9):e0138657. PubMed ID: 26390126
[TBL] [Abstract][Full Text] [Related]
13. Impact of the Preoperative C-reactive Protein to Albumin Ratio on the Long-Term Outcomes of Hepatic Resection for Intrahepatic Cholangiocarcinoma.
Ito T; Shinkawa H; Takemura S; Tanaka S; Nishioka T; Miyazaki T; Ishihara A; Kubo S
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2373-2379. PubMed ID: 32856868
[TBL] [Abstract][Full Text] [Related]
14. The Ratio of C-Reactive Protein/Albumin is a Novel Inflammatory Predictor of Overall Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma.
Sun P; Chen C; Xia Y; Bi X; Liu P; Zhang F; Yang H; An X; Jiang W; Wang F
Dis Markers; 2017; 2017():6570808. PubMed ID: 28676731
[TBL] [Abstract][Full Text] [Related]
15. Risk stratification in oral cavity squamous cell carcinoma by preoperative CRP and SCC antigen levels.
Huang SF; Wei FC; Liao CT; Wang HM; Lin CY; Lo S; Huang JJ; Chen IH; Kang CJ; Chien HT; Chen HH
Ann Surg Oncol; 2012 Nov; 19(12):3856-64. PubMed ID: 22576068
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of preoperative C-reactive protein: albumin ratio in patients with clear cell renal cell carcinoma.
Chen Z; Shao Y; Fan M; Zhuang Q; Wang K; Cao W; Xu X; He X
Int J Clin Exp Pathol; 2015; 8(11):14893-900. PubMed ID: 26823819
[TBL] [Abstract][Full Text] [Related]
17. The C-reactive Protein to Albumin Ratio Predicts Long-Term Outcomes in Patients with Pancreatic Cancer After Pancreatic Resection.
Haruki K; Shiba H; Shirai Y; Horiuchi T; Iwase R; Fujiwara Y; Furukawa K; Misawa T; Yanaga K
World J Surg; 2016 Sep; 40(9):2254-60. PubMed ID: 26956901
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin and Neutrophil-Lymphocyte Ratio in Gastric Cancer Patients.
Saito H; Kono Y; Murakami Y; Shishido Y; Kuroda H; Matsunaga T; Fukumoto Y; Osaki T; Ashida K; Fujiwara Y
World J Surg; 2018 Jun; 42(6):1819-1825. PubMed ID: 29270656
[TBL] [Abstract][Full Text] [Related]
19. Refining the role of preoperative C-reactive protein by neutrophil/lymphocyte ratio in oral cavity squamous cell carcinoma.
Fang HY; Huang XY; Chien HT; Chang JT; Liao CT; Huang JJ; Wei FC; Wang HM; Chen IH; Kang CJ; Huang SF
Laryngoscope; 2013 Nov; 123(11):2690-9. PubMed ID: 23619955
[TBL] [Abstract][Full Text] [Related]
20. Clinical Implication of Pre-operative C-reactive Protein-Albumin Ratio as a Prognostic Factor of Patients With Pancreatic Ductal Adenocarcinoma: A Single-institutional Retrospective Study.
Murakawa M; Yamamoto N; Kamioka Y; Kamiya M; Kobayashi S; Ueno M; Morimoto M; Atsumi Y; Aoyama T; Tamagawa H; Yukawa N; Rino Y; Masuda M; Morinaga S
In Vivo; 2020; 34(1):347-353. PubMed ID: 31882498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
